🇺🇸 FDA
Patent

US 8680056

Antiproliferative factor and methods of use

granted A61KA61K38/00

Quick answer

US patent 8680056 (Antiproliferative factor and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00